Impact of IDH1 and IDH2 Mutation Detection at Diagnosis and in Remission in Acute Myeloid Leukemia Patients Receiving Allogeneic Transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Leipzig, Universität Leipzig, Dissertation, 2024
- Keyword
-
Leukämie
- Event
-
Veröffentlichung
- (where)
-
Leipzig
- (who)
-
Universitätsbibliothek Leipzig
- (when)
-
2024
- Creator
- URN
-
urn:nbn:de:bsz:15-qucosa2-905272
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bill, Marius
- Universitätsbibliothek Leipzig
Time of origin
- 2024
Other Objects (12)
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Prognostic Impact of the CD34+/CD38- Cell Burden in Patients with Acute Myeloid Leukemia receiving Allogeneic Stem Cell Transplantation
Treatment-free remission in chronic myeloid leukemia
A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Prognostic Impact of the CD34+/CD38- Cell Burden in Patients with Acute Myeloid Leukemia receiving Allogeneic Stem Cell Transplantation
Treatment-free remission in chronic myeloid leukemia
A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Prognostic Impact of the CD34+/CD38- Cell Burden in Patients with Acute Myeloid Leukemia receiving Allogeneic Stem Cell Transplantation
Treatment-free remission in chronic myeloid leukemia